Clinical Trials Directory

Trials / Terminated

TerminatedNCT02766088

This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia

A Cohort Study to Assess the Burden of Dengue Illness in Household Members From Selected Communities in Southeast Asia and Latin America

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
1,750 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
6 Months – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to describe the burden of DENV illness among household members aged 6 months to 50 years of selected communities in Latin America and Southeast Asia.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood sample collectionAll participants will have an enrolment visit with collection of a blood sample and a termination contact/visit. Participants or their parents/guardians will be contacted weekly or every two weeks to monitor the occurrence of febrile episodes. Additional visits will be made if febrile episodes occur. In case of dengue suspicion, a blood sample will be collected.

Timeline

Start date
2016-07-14
Primary completion
2018-12-14
Completion
2018-12-14
First posted
2016-05-09
Last updated
2024-03-15
Results posted
2020-04-27

Locations

2 sites across 2 countries: Mexico, Philippines

Source: ClinicalTrials.gov record NCT02766088. Inclusion in this directory is not an endorsement.

This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Yea (NCT02766088) · Clinical Trials Directory